These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 270523)

  • 1. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization.
    McLaren C; Potter CW; Jennings R
    J Hyg (Lond); 1974 Dec; 73(3):389-99. PubMed ID: 4531448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A contribution of cellular immunity to protection against influenza in man.
    Jennings R; Fenton RJ; McEntegart MG; Potter CW
    Med Microbiol Immunol; 1978 Nov; 166(1-4):51-62. PubMed ID: 723791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2).
    Larson HE; Tyrrell DA; Bowker CH; Potter CW; Schild GC
    J Hyg (Lond); 1978 Apr; 80(2):243-8. PubMed ID: 632564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG; Downie JC; Webster RG
    J Immunol; 1976 Feb; 116(2):336-41. PubMed ID: 55438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
    Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
    Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.
    Jennings R; Clark A; Oxford JS; Hockley DJ; Potter CW
    J Infect Dis; 1978 Nov; 138(5):577-86. PubMed ID: 712115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.
    Schild GC; Oxford JS; Dowdle WR; Coleman M; Pereira MS; Chakraverty P
    Bull World Health Organ; 1974; 51(1):1-11. PubMed ID: 4218138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.